Articles From: Acceleron Pharma Reports Third Quarter 2014 Financial and Operational Results to Accenture Positioned as a Leader in Worldwide Cloud Professional Services for Second Consecutive Year, According to IDC MarketScape


Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today provided a corporate update and reported financial results for the third quarter ended September 30, 2014.
Sign-up for Acceleron Pharma Reports Third Quarter 2014 Financial and Operational Results investment picks
Acceleron Pharma Inc. (NASDAQ: XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced that the company will host a conference call and live audio webcast to report its third quarter 2014 financial results and provide a corporate update on Friday, November 7, 2014, at 9:00 AM EST.
Sign-up for Acceleron Pharma to Host Third Quarter 2014 Financial Results Conference Call and Webcast on November 7, 2014 investment picks
Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced it will participate in several upcoming investor conferences.
Sign-up for Acceleron Pharma to Present at Upcoming Investor Conferences in December investment picks
Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced it will participate in several upcoming investor conferences.
Sign-up for Acceleron Pharma to Present at Upcoming Investor Conferences in November investment picks
Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced results from an interim report for a two-part clinical study sponsored by the Gynecology Oncology Group evaluating dalantercept as monotherapy in patients with recurrent or persistent epithelial ovarian cancer.
Sign-up for Acceleron Provides Update on Externally Sponsored Clinical Trial of Dalantercept Monotherapy in Ovarian Cancer investment picks
Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced it will host and webcast an online educational seminar on beta-thalassemia with Ellis Neufeld, M.D., Ph.D. Acceleron and its collaboration partner, Celgene, are conducting phase 2 clinical trials of sotatercept and luspatercept in patients with beta-thalassemia, MDS, and end-stage renal disease with mineral and bone disorder.
Sign-up for Acceleron to Host Educational Webcast on Beta-thalassemia investment picks
Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced that it plans to host and webcast a series of online seminars with thought-leading experts in diseases for which sotatercept and luspatercept (ACE-536) are being developed.
Sign-up for Acceleron to Host Educational Webcast Series with Clinical Thought Leaders investment picks
Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced it will present a corporate overview at the Leerink Partners Rare Disease Roundtable on Wednesday, October 1, 2014 at 10:15 a.m. EDT at Le Parker Meridien Hotel in New York City.
Sign-up for Acceleron to Webcast Presentation at Leerink Partners Rare Disease Roundtable investment picks
Accenture (NYSE:ACN) and Alcatel-Lucent (Euronext Paris and NYSE: ALU) have formed a strategic alliance to help communications service providers (CSPs) and large enterprises implement integrated ultra-broadband solutions to address the challenges of rising costs and increased data consumption caused by high demand from digital customers and applications.
Sign-up for Accenture and Alcatel-Lucent Collaborate to Help Clients Monetize Ultra-Broadband Opportunities investment picks
Accenture (NYSE:ACN) and Backbase, a leading provider of customer experience management technology solutions, have entered into an alliance agreement in financial services to enable banking clients to improve customer engagement through digital channels.
Sign-up for Accenture and Backbase Form Alliance in Financial Services to Help Banks Improve Customer Engagement through Digital Channels investment picks
As the volume of business-to-business (B2B) purchases being made online continues to grow, B2B suppliers are responding by expanding their e-commerce platforms and overall omni-channel capabilities, according to new research from Accenture (NYSE:ACN) and hybris software, an SAP company.
Sign-up for Accenture and hybris Study Finds B2B Suppliers Are Investing in E-Commerce to Deliver Better Purchasing Experience for Business Buyers investment picks
Accenture (NYSE:ACN) and Microsoft Corp.
Sign-up for Accenture and Microsoft Launch New Hybrid Cloud Platform to Accelerate Enterprise-Wide Adoption investment picks
Accenture (NYSE:ACN) today announced that it has created its first solution in a suite of solutions to help life sciences companies improve customer and patient engagement leveraging cloud, social and mobile technologies.
Sign-up for Accenture and Salesforce.com Collaborate to Help the Healthcare Industry Improve Customer and Patient Outcomes investment picks
Accenture (NYSE:ACN) and SAP SE (NYSE:SAP) today announced a new version of the SAP® Upstream Operations Management application, which enables oil and gas companies to improve the accuracy of production data and identify production-optimization opportunities.
Sign-up for Accenture and SAP Announce New Upstream Operations Management Solution to Simplify Monitoring and Managing Production for Oil and Gas Companies investment picks
2014/10/7
Accenture Federal Services will develop a new maintenance system featuring mobile devices to help increase efficiencies and generate cost savings for the U.S. Department of the Navy’s shipyard maintenance operations.
Sign-up for Accenture Awarded $16.3 Million Contract To Develop Mobile Maintenance Support System for the U.S. Navy investment picks
Accenture (NYSE:ACN) has awarded $895,000 to the Institute for Veterans and Military Families at Syracuse University (IVMF) to help the organization deliver educational, employment and life-skills training that enable veterans and their families to transition from military to civilian life.
Sign-up for Accenture Awards $895,000 to the Institute for Veterans and Military Families investment picks
Accenture (NYSE:ACN) is collaborating with Wire and Wireless Co., Ltd.
Sign-up for Accenture Collaborates with Wire and Wireless Co. in its “Travel Japan Wi-Fi” Initiative to Create Innovative Services for Tourists investment picks
2014/11/6
Accenture Federal Services has delivered an integrated enterprise resource planning system that will help the National Capitol Region Medical Directorate (NCR MD) manage healthcare services for one of the largest military markets in the nation.
Sign-up for Accenture Expands Army Financial System to Better Serve Military Health Community investment picks
Accenture (NYSE:ACN) is expanding its Workday (NYSE:WDAY) global delivery capabilities with the launch of the Accenture Solution Factory for Workday.
Sign-up for Accenture Expands Its Workday Global Delivery Capabilities with Accenture Solution Factory for Workday investment picks
Accenture (NYSE:ACN) and VSO announced that Accenture and the Accenture Foundations have awarded VSO US$3.5 million to help the charity deliver job skills training to approximately 22,300 poor and disadvantaged people in Nigeria, Cambodia, Tanzania and Malawi.
Sign-up for Accenture Grants VSO US$3.5 Million to Equip People Across Africa with Job and Entrepreneurial Skills investment picks
Zurich Insurance Group (Zurich) has gone live with its new global corporate website ( www.zurich.com ) that was built with help from Accenture (NYSE:ACN). Zurich’s website was revamped to enhance digital interactions with consumers and better support its global digital marketing strategy.
Sign-up for Accenture Helps Zurich Insurance Group Revamp Global Corporate Website to Support Digital Marketing Strategy investment picks
Accenture (NYSE:ACN) was positioned in the “Leaders” quadrant in Gartner’s recently published “Magic Quadrant for North American Life Insurance Policy Administration Systems 1 ” evaluated for its Accenture Life Insurance Platform .
Sign-up for Accenture Improves Position in “Leaders” Quadrant of Gartner’s Magic Quadrant for North American Life Insurance Policy Administration Systems investment picks
Accenture (NYSE:ACN) announced a new technology capability for its Duck Creek property & casualty software that provides global alliance partners with access to its software product definitions and the ability to pre-integrate the technology into their systems prior to deployment.
Sign-up for Accenture Introduces New Capabilities to Enhance Delivery of Pre-Integrated Duck Creek Property & Casualty Insurance Software to Clients investment picks
Accenture (NYSE:ACN) is launching the Accenture Innovation Center for Oracle Engineered Systems, enabling faster and more cost-effective deployment of Oracle solutions for clients.
Sign-up for Accenture Launches New Innovation Center for Oracle Engineered Systems to Help Clients Accelerate and Simplify Deployment of Oracle Technologies investment picks
Accenture (NYSE:ACN) has been named to the 'Winner's Circle' of HfS Research's Blueprint Report for SAP Services.
Sign-up for Accenture Maintains Lead Position in ‘Winner's Circle’ for SAP Services for Second Consecutive Year, According to HfS Research Report investment picks
Accenture (NYSE:ACN), in cooperation with SAP SE (NYSE:SAP), today announced the launch of an Upstream Solution for Independents, an end-to-end technology platform designed for medium- and small-sized independent oil and gas companies in North America.
Sign-up for Accenture Plans to Launch Upstream Solution for Independent Oil and Gas Companies on the SAP HANA® Cloud Platform investment picks
Accenture (NYSE:ACN) has been positioned in the “Leaders” quadrant in Gartner’s new, recently published “Magic Quadrant for Global Risk Management Consulting Services.
Sign-up for Accenture Positioned as a Leader in Gartner’s New Magic Quadrant for Global Risk Management Consulting Services investment picks
Accenture (NYSE:ACN) has been positioned as a “Leader” in the recently published report, “IDC MarketScape: Worldwide Oracle Implementation Services Ecosystem 2014 Vendor Analysis.” 1 The report represents a vendor assessment, including both qualitative and quantitative characteristics, of the 2014 Oracle implementation services market.
Sign-up for Accenture Positioned as a Leader in the new IDC MarketScape: Worldwide Oracle Implementation Services Ecosystem investment picks
Accenture (NYSE: ACN) has been positioned as a “Leader” in cloud professional services, according to the “IDC MarketScape: Worldwide Cloud Professional Services 2014 Vendor Analysis 1 .” Receiving this distinction for the second consecutive year, Accenture is recognized for its deep industry knowledge, ecosystem relationships, and experience as a service integrator and outsourcer to create differentiated cloud solutions that address clients' unique needs.
Sign-up for Accenture Positioned as a Leader in Worldwide Cloud Professional Services for Second Consecutive Year, According to IDC MarketScape investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Acceleron Pharma Reports Third Quarter 2014 Financial and Operational Results to Accenture Positioned as a Leader in Worldwide Cloud Professional Services for Second Consecutive Year, According to IDC MarketScape
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent